<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.0 20040830//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Genet</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosgen</journal-id><journal-title-group><journal-title>PLoS Genetics</journal-title></journal-title-group><issn pub-type="ppub">1553-7390</issn><issn pub-type="epub">1553-7404</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">09-PLGE-RA-1056R2</article-id><article-id pub-id-type="doi">10.1371/journal.pgen.1000689</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Evolutionary Biology/Microbial Evolution and Genomics</subject><subject>Genetics and Genomics/Gene Expression</subject><subject>Genetics and Genomics/Microbial Evolution and Genomics</subject><subject>Microbiology/Microbial Evolution and Genomics</subject></subj-group></article-categories><title-group><article-title>A Novel Mechanism of Transposon-Mediated Gene Activation</article-title><alt-title alt-title-type="running-head">Mechanism of Transposon-Mediated Gene Activation</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Zhongge</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Saier</surname><given-names>Milton H.</given-names><suffix>Jr</suffix></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Division of Biological Sciences, University of California San Diego, La Jolla, California, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Casades&#x000fa;s</surname><given-names>Josep</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Universidad de Sevilla, Spain</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>msaier@ucsd.edu</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: ZZ MHS. Performed the experiments: ZZ. Analyzed the data: ZZ MHS. Contributed reagents/materials/analysis tools: ZZ. Wrote the paper: ZZ MHS.</p></fn></author-notes><pub-date pub-type="collection"><month>10</month><year>2009</year></pub-date><!-- Fake ppub added to accomodate plos workflow change from 03/2008 and 03/2009 --><pub-date pub-type="ppub"><month>10</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>16</day><month>10</month><year>2009</year></pub-date><volume>5</volume><issue>10</issue><elocation-id>e1000689</elocation-id><history><date date-type="received"><day>23</day><month>6</month><year>2009</year></date><date date-type="accepted"><day>17</day><month>9</month><year>2009</year></date></history><permissions><copyright-statement>Zhang, Saier. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement></permissions><abstract><p>Transposable Insertion Sequences (IS elements) have been shown to provide various benefits to their hosts via gene activation or inactivation under stress conditions by appropriately inserting into specific chromosomal sites. Activation is usually due to derepression or introduction of a complete or partial promoter located within the element. Here we define a novel mechanism of gene activation by the transposon IS5 in <italic>Escherichia coli</italic>. The glycerol utilization operon, <italic>glpFK</italic>, that is silent in the absence of the cAMP-Crp complex, is activated by IS5 when inserted upstream of its promoter. High-level expression is nearly constitutive, only mildly dependent on glycerol, glucose, GlpR, and Crp, and allows growth at a rate similar to or more rapid than that of wild-type cells. Expression is from the <italic>glpFK</italic> promoter and dependent on (1) the DNA phase, (2) integration host factor (IHF), and (3) a short region at the 3&#x02032; end of IS5 harboring a permanent bend and an IHF binding site. The <italic>lacZYA</italic> operon is also subject to such activation in the absence of Crp. Thus, we have defined a novel mechanism of gene activation involving transposon insertion that may be generally applicable to many organisms.</p></abstract><abstract abstract-type="summary"><title>Author Summary</title><p>Transposons are &#x0201c;jumping genes&#x0201d; that can move from one location within a genome to another. Insertion of a transponson changes the DNA sequence and therefore gives rise to mutations that can activate or inactivate gene expression. Here, we demonstrate for the first time that one such transposon, Insertion Sequence 5 (IS5), when positioned upstream of a metabolic operon (<italic>glpFK</italic>) of <italic>E. coli</italic>, can activate the otherwise cryptic expression of the operon. This effect is due solely to a short region at the 3&#x02032; end of IS5 that harbors a permanent bend and an overlapping nucleoid protein binding site, both of which are required for maximal gene expression. We demonstrate the importance of phasing and conclude that DNA looping probably plays a role. We also show that another operon, the <italic>E. coli</italic> lactose operon (<italic>lacZYA</italic>), can be similarly activated by IS5. Although this is the first study to show that unique sequences within a transposon are necessary and sufficient to activate a downstream silent promoter, similar mechanisms of gene activation may occur for other operons.</p></abstract><counts><page-count count="9"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Living organisms possess a variety of mutagenic means to generate genetic diversity, and these depend on environmental conditions and genomic composition <xref ref-type="bibr" rid="pgen.1000689-Friedberg1">&#x0005b;1&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000689-HenggeAronis1">&#x0005b;2&#x0005d;</xref>. One frequently encountered type of mutation results from the insertion of transposable elements, transposons, which when inserted in appropriate locations of the genome, can activate or inactivate critical genes <xref ref-type="bibr" rid="pgen.1000689-Chandler1">&#x0005b;3&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000689-Mahillon1">&#x0005b;4&#x0005d;</xref>. One transposon-mediated mechanism of gene activation involves the formation of a &#x0201c;hybrid promoter&#x0201d; when a small transposon, an Insertion Sequence (IS) element, inserts into the promoter region. In this case, insertion of an IS element results in placing an outwardly directed &#x02212;35 hexamer in one of the terminal inverted repeats (IRs) of the transposon at the correct distance from a resident &#x02212;10 hexamer. Such &#x02212;35 elements have been observed experimentally in several ISs <xref ref-type="bibr" rid="pgen.1000689-Galas1">&#x0005b;5&#x0005d;</xref>. Activation can also occur by initiating transcription within the transposon, traversing the terminal IR and reading the gene of interest. This second type of mechanism has been observed for IS3 <xref ref-type="bibr" rid="pgen.1000689-Charlier1">&#x0005b;6&#x0005d;</xref> and IS10 <xref ref-type="bibr" rid="pgen.1000689-Ciampi1">&#x0005b;7&#x0005d;</xref>.</p><p>A distinct type of gene regulation by ISs is illustrated by activation of the normally cryptic &#x003b2;-glucoside (<italic>bgl</italic>) catabolic operon in <italic>E. coli</italic>. Activation of this operon can be accomplished in several ways, one of which involves insertion of either IS5 or IS1 upstream or downstream of the promoter <xref ref-type="bibr" rid="pgen.1000689-Reynolds1">&#x0005b;8&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000689-Schnetz1">&#x0005b;9&#x0005d;</xref>. For <italic>bgl</italic> operon activation, IS5 need not be in a specific position and orientation <xref ref-type="bibr" rid="pgen.1000689-Schnetz1">&#x0005b;9&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000689-Schnetz2">&#x0005b;10&#x0005d;</xref>, and the nucleoid structuring protein H-NS is required <xref ref-type="bibr" rid="pgen.1000689-Dole1">&#x0005b;11&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000689-Mukerji1">&#x0005b;12&#x0005d;</xref>.</p><p>The IS5 element has been found to activate the <italic>fucAO</italic> promoter <xref ref-type="bibr" rid="pgen.1000689-Chen1">&#x0005b;13&#x0005d;</xref>, the <italic>flhDC</italic> promoter <xref ref-type="bibr" rid="pgen.1000689-Barker1">&#x0005b;14&#x0005d;</xref>, and the <italic>ade</italic> promoter <xref ref-type="bibr" rid="pgen.1000689-Petersen1">&#x0005b;15&#x0005d;</xref>. In wild type (<italic>wt</italic>) <italic>E. coli</italic> cells, expression of the <italic>fucAO</italic> operon is dependent on FucR, an activator of the <italic>fuc</italic> genes, and the cyclic AMP receptor protein (Crp). Prolonged incubation of <italic>wt</italic> cells with L-1,2-propanediol (which does not activate FucR) produced mutants that could grow on this carbon source. These mutants express <italic>fucAO</italic> independently of FucR and harbor IS5 inserted upstream of the <italic>fucAO</italic> promoter, always in the same orientation with its <italic>ins5A</italic> promoter distal to <italic>fucA</italic><xref ref-type="bibr" rid="pgen.1000689-Chen1">&#x0005b;13&#x0005d;</xref>. In the case of <italic>flhDC</italic>, motility of <italic>wt</italic> cells on semisolid agar is substantially enhanced when IS5 is inserted at either of two locations (&#x02212;99.5 and &#x02212;169.5) upstream of the transcriptional start site. The IS5 orientations proved to be the same, with the <italic>ins5A</italic> promoter distal to the downstream <italic>flhDC</italic> promoter <xref ref-type="bibr" rid="pgen.1000689-Barker1">&#x0005b;14&#x0005d;</xref>, as in the case of IS5 insertion in the <italic>fucAO</italic> promoter. In addition, IS5 has been shown to activate the cryptic <italic>ade</italic> gene encoding an adenine deaminase that catalyzes deamination of adenine to hypoxanthine in <italic>E. coli</italic><xref ref-type="bibr" rid="pgen.1000689-Petersen1">&#x0005b;15&#x0005d;</xref>. In the cases of <italic>flhDC</italic> and <italic>ade</italic>, activation is proposed to be due to the relief of HNS-mediated normal repression by IS5 insertion <xref ref-type="bibr" rid="pgen.1000689-Barker1">&#x0005b;14&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000689-Petersen1">&#x0005b;15&#x0005d;</xref> but the mechanism of IS5 activation of the <italic>fucAO</italic> promoter is unknown <xref ref-type="bibr" rid="pgen.1000689-Chen1">&#x0005b;13&#x0005d;</xref>.</p><p><italic>E. coli</italic> can use glycerol, glycerol-3-phosphate, or glycerophosphodiesters as sole carbon and energy sources. The loss of Crp abolishes its growth on glycerol. This is due to the fact that expression of one operon in the <italic>glp</italic> regulon, <italic>glpFK</italic>, encoding proteins essential for glycerol utilization <xref ref-type="bibr" rid="pgen.1000689-Lin1">&#x0005b;16&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000689-Zhao1">&#x0005b;17&#x0005d;</xref>, is strongly dependent on the Crp-cAMP complex (<xref ref-type="fig" rid="pgen-1000689-g001">Figure 1</xref>) <xref ref-type="bibr" rid="pgen.1000689-Freedberg1">&#x0005b;18&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000689-Weissenborn1">&#x0005b;19&#x0005d;</xref>. In addition, <italic>glpFK</italic> expression is repressed by the binding of GlpR, the <italic>glp</italic> regulon repressor, to the four operators in the <italic>glpFK</italic> promoter region (<xref ref-type="fig" rid="pgen-1000689-g001">Figure 1</xref>) <xref ref-type="bibr" rid="pgen.1000689-Zeng1">&#x0005b;20&#x0005d;</xref>. Repression is relieved in the presence of glycerol-3-phosphate, the inducer of the <italic>glp</italic> regulon.</p><fig id="pgen-1000689-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000689.g001</object-id><label>Figure 1</label><caption><title>Schematic diagram of IS5 and its various regions upstream of the <italic>glpFK</italic> promoter (P<italic>glpFK</italic>) region used in this study (A), the 177-bp region (IB) at the 3&#x02032; end of IS5 and the <italic>glpFK</italic> promoter region (B).</title><p>In (A), the numbers are relative to the 5&#x02032; end of IS5. IS5, P-less IS5, IB, and 178 bp refer to the entire IS5, IS5 deleted for the 98 bps from the 5&#x02032; end, the 177 bp 3&#x02032; end region of IS5 (IB), and the 178 bp region between the 226th and the 403rd nucleotides of IS5, respectively. In (B), the junction between IB and P<italic>glpFK</italic> is marked by an &#x0002a;. In IB, A-tracts are capitalized and numbered, and the IHF binding site is underlined. Mutations introduced into the IHF binding site or the A-tracts are labeled with letters above the sequence. In P<italic>glpFK</italic>, the &#x0002b;1, the promoter region (&#x02212;10 and &#x02212;35), the ribosome binding site (RBS) and the start codon for <italic>glpF</italic> are shaded. The GlpR binding sites are overlined and the Crp binding sites are underlined. The IS5 insertion site (CTAA) is shaded.</p></caption><graphic xlink:href="pgen.1000689.g001"/></fig><p>Our previous research <xref ref-type="bibr" rid="pgen.1000689-Zhang1">&#x0005b;21&#x0005d;</xref> demonstrated that <italic>crp</italic> deletion mutants can mutate specifically to utilize glycerol (Glp<sup>&#x0002b;</sup>). The frequencies of such mutations are enhanced by the presence of glycerol and decreased by GlpR. Of the four GlpR operators (<italic>O1</italic>-<italic>O4</italic>) upstream of <italic>glpFK</italic>, <italic>O1</italic> primarily controls mutation rate while <italic>O4</italic> specifically controls <italic>glpFK</italic> expression. All Glp<sup>&#x0002b;</sup> mutants contain an IS5 upstream of the <italic>glpFK</italic> promoter, always in the same position and orientation <xref ref-type="bibr" rid="pgen.1000689-Zhang1">&#x0005b;21&#x0005d;</xref>.</p><p>Here, we describe a novel mechanism of gene activation due to IS5 insertion upstream of the promoter of the <italic>glpFK</italic> operon. Activation is so strong that it overcomes the repression resulting from the absence of Crp. A 177-bp fragment at the 3&#x02032; end of IS5, proximal to the downstream promoter, is both necessary and sufficient for full activation. Although for activation, IS5 always inserts into the same position upstream of the <italic>glpFK</italic> promoter, the activating effect is still observed when a 10 bp fragment, but not a 5 bp fragment, is inserted between IS5 and the <italic>glpFK</italic> promoter. Thus, the active element, encompassing a permanent bend and an IHF binding site, must be present at the correct phase angle relative to the promoter to be effective. Finally, it is shown that in the absence of Crp, the <italic>E. coli</italic> lactose operon can also be activated by upstream IS5 insertion. These results reveal a novel mechanism of gene activation by insertion sequences.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Effects of IS5 Insertion on Expression of <italic>glp</italic> Genes in Various Genetic Backgrounds</title><p>Using real-time PCR, we determined mRNA levels of the five <italic>glp</italic> operons comparing <italic>crp</italic> Glp<sup>&#x0002b;</sup> cells (with an IS5 insertion upstream of the <italic>glpFK</italic> promoter) <xref ref-type="bibr" rid="pgen.1000689-Zhang1">&#x0005b;21&#x0005d;</xref> with parental <italic>crp</italic> cells. No differences were observed in expression levels of four of the five operons, but the <italic>glpFK</italic> operon showed a dramatic difference. <xref ref-type="fig" rid="pgen-1000689-g002">Figure 2A</xref> shows expression of <italic>glpFK</italic> in <italic>wt</italic>, <italic>crp</italic> and <italic>crp</italic> Glp<sup>&#x0002b;</sup> cells. In the absence of glycerol, <italic>glpFK</italic> expression was &#x0003e;50 fold higher in <italic>crp</italic> Glp<sup>&#x0002b;</sup> cells than in <italic>crp</italic> cells (see columns 3 and 5 from the left side), showing that the IS5 insertion led to high level expression of this operon. In the presence of glycerol, <italic>glpFK</italic> expression increased in all cell types examined, but expression was the highest in <italic>crp</italic> Glp<sup>&#x0002b;</sup> cells, about 15-fold higher than in the <italic>crp</italic> cells incubated under the same conditions. However, the degree of induction by glycerol in <italic>crp</italic> Glp<sup>&#x0002b;</sup> cells was greatly decreased, suggesting that in these cells, repression by GlpR is weak (&#x0223c;2.5 fold, see columns 5 and 6) compared to that in <italic>wt</italic> cells (&#x0003e;10 fold, see columns 1 and 2).</p><fig id="pgen-1000689-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000689.g002</object-id><label>Figure 2</label><caption><title>Real time PCR analysis of <italic>glpFK</italic> expression (A,B) and determination of glycerol kinase (GlpK) activity (C).</title><p>(A) <italic>glpFK</italic> mRNA levels in <italic>wt</italic>, <italic>crp</italic> and <italic>crp</italic> Glp<sup>&#x0002b;</sup> cells. (B) <italic>glpFK</italic> mRNA levels in <italic>glpR</italic>, <italic>crp glpR</italic> and <italic>crp glpR</italic> Glp<sup>&#x0002b;</sup> cells. (C) Glycerol kinase (GlpK) activities in <italic>wt</italic>, <italic>crp</italic>, and <italic>crp</italic> Glp<sup>&#x0002b;</sup> cells. Cells were grown in LB with or without 1&#x00025; glycerol (Gly). Radioactivity was measured by scintillation counting with 10 ml of Bio-safe II fluid.</p></caption><graphic xlink:href="pgen.1000689.g002"/></fig><p>When the <italic>glpR</italic> gene was deleted from each of these three backgrounds, glycerol induction of <italic>glpFK</italic> expression was abolished (<xref ref-type="fig" rid="pgen-1000689-g002">Figure 2B</xref>), indicating that increased <italic>glpFK</italic> expression in <italic>wt</italic>, <italic>crp</italic> and <italic>crp</italic> Glp<sup>&#x0002b;</sup> cells in response to glycerol is solely due to the release of GlpR from the control region of the operon.</p><p>We measured <italic>in vitro</italic> glycerol kinase activity in <italic>wt</italic>, <italic>crp</italic> and <italic>crp</italic> Glp<sup>&#x0002b;</sup> cells using &#x0005b;<sup>14</sup>C&#x0005d;glycerol as substrate. The highest levels of glycerol phosphorylation activity were observed in extracts of <italic>crp</italic> Glp<sup>&#x0002b;</sup> cells cultured in LB medium either with or without glycerol (<xref ref-type="fig" rid="pgen-1000689-g002">Figure 2C</xref>). Glycerol induction was observed in all three genetic backgrounds, with induction levels similar to those of the mRNA revealed by real-time PCR (see <xref ref-type="fig" rid="pgen-1000689-g002">Figure 2A</xref>).</p><p>To test if IS5 activation of the <italic>glpFK</italic> promoter (P<italic>glpFK</italic>) is due to relief of repression by H-NS as observed for the <italic>bgl</italic> operon <xref ref-type="bibr" rid="pgen.1000689-Dole1">&#x0005b;11&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000689-Mukerji1">&#x0005b;12&#x0005d;</xref> and the <italic>ade</italic> operon <xref ref-type="bibr" rid="pgen.1000689-Petersen1">&#x0005b;15&#x0005d;</xref>, we mutated the <italic>hns</italic> gene in <italic>wt</italic>, <italic>crp</italic> and <italic>crp</italic> Glp<sup>&#x0002b;</sup> backgrounds. Using real-time PCR, we found that the <italic>hns</italic> mutation had only a slight (&#x0003c;0.2 fold) effect on <italic>glpFK</italic> expression in all three genetic backgrounds compared to the same cells without the <italic>hns</italic> mutation (<xref ref-type="supplementary-material" rid="pgen.1000689.s001">Figure S1</xref>), indicating that IS5 activation of P<italic>glpFK</italic> in the absence of Crp is not due to relief of H-NS mediated repression.</p></sec><sec id="s2b"><title>Determination of the Start Site of <italic>glpFK</italic> Transcription in <italic>crp</italic> Glp<sup>&#x0002b;</sup> Mutants</title><p>To determine if the presence of the IS5 element provides a new promoter driving <italic>glpFK</italic> transcription, we measured the transcriptional initiation site of the operon using RNA ligase mediated RT-PCR. The total RNA was treated with tobacco acid pyrophosphatase (TAP) prior to cDNA synthesis. The 5&#x02032;-end region of the <italic>glpFK</italic> cDNA was amplified using a pair of primers (<xref ref-type="supplementary-material" rid="pgen.1000689.s006">Table S2</xref>), one (PglpFK-extn-F) binding to the adaptor sequence and the other (PglpFK-extn-R) binding to a region between 115<sup>th</sup> and 137<sup>th</sup> nucleotides downstream of the <italic>glpF</italic> start codon. Two PCR products were obtained for both the wild type and the <italic>crp</italic> Glp<sup>&#x0002b;</sup> strain (<xref ref-type="fig" rid="pgen-1000689-g003">Figure 3A</xref>). Using PglpFK-extn-R as primer, DNA sequencing showed that the larger product was non-specific; the smaller one was the 5&#x02032;-end region of the <italic>glpFK</italic> cDNA product (<xref ref-type="fig" rid="pgen-1000689-g003">Figure 3B</xref>). The junction was found to correspond precisely to the 5&#x02032; end mapped by primer extension (see <xref ref-type="fig" rid="pgen-1000689-g001">Figure 1B</xref>) <xref ref-type="bibr" rid="pgen.1000689-Freedberg1">&#x0005b;18&#x0005d;</xref>. When the total RNA was not treated with TAP, only the nonspecific PCR product was obtained (see <xref ref-type="fig" rid="pgen-1000689-g003">Figure 3A</xref>) for both the wild type and the <italic>crp</italic> Glp<sup>&#x0002b;</sup> strains. Activation of transcription by IS5 in <italic>crp</italic> Glp<sup>&#x0002b;</sup> cells is therefore driven by the native <italic>glpFK</italic> promoter. The start site was the same with or without glycerol (1&#x00025;) in the growth medium.</p><fig id="pgen-1000689-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000689.g003</object-id><label>Figure 3</label><caption><title>Analysis of the 5&#x02032; end of the <italic>glpFK</italic> message.</title><p>(A) Gel electrophoresis of PCR products of the 5&#x02032; end of the <italic>glpFK</italic> cDNA. RNA ligase-mediated RT&#x02013;PCR was employed to amplify the 5&#x02032; end of the <italic>glpFK</italic> mRNA. cDNA was synthesized using an Invitrogen superscript first-strand synthesis kit. The arrow points to the product resulting from a newly initiated message. The other band is a nonspecific PCR product. (B) Chromatogram of a part of the DNA sequence showing the junction between the 5&#x02032; end of the <italic>glpFK</italic> cDNA and the reverse transcribed adaptor. The amplified 5&#x02032; end of the <italic>glpFK</italic> cDNA was sequenced using the oligo PglpFK-extn-R (see <xref ref-type="supplementary-material" rid="pgen.1000689.s006">Table S2</xref>) that binds to the &#x0223c;210 bp region downstream of &#x0002b;1. The arrow points to the transcriptional start site (&#x0002b;1) on the complementary strand.</p></caption><graphic xlink:href="pgen.1000689.g003"/></fig></sec><sec id="s2c"><title>Effects of Different Regions within IS5 on <italic>glpFK</italic> Promoter Activity</title><p>Using chromosomal <italic>lacZ</italic> fusions, we examined the effect of IS5 and different regions within IS5 on P<italic>glpFK</italic> activity (<xref ref-type="fig" rid="pgen-1000689-g001">Figure 1A</xref> and <xref ref-type="fig" rid="pgen-1000689-g004">Figure 4A</xref>). Consistent with the RT-PCR results, the presence of IS5 upstream of P<italic>glpFK</italic> (IS5:P<italic>glpFK</italic>) in <italic>crp</italic> cells dramatically increased the activity of the promoter regardless of the medium used. Both promoter-less IS5 (P-less IS5, in which the 98 bp 5&#x02032; end region containing the promoter of the transposase gene was deleted), and the 177 bp 3&#x02032; end region (called &#x0201c;Internal Bend&#x0201d;, IB) of IS5 activated P<italic>glpFK</italic> in <italic>crp</italic> cells to an extent comparable to that observed with the intact IS5. However, the 130 bp 3&#x02032; end region of IS5 (i.e., IB with 47 nucleotides removed from the 5&#x02032; end) activated the promoter about 40&#x00025; less efficiently than the 177 bp IB region (data not shown, see below for explanation).</p><fig id="pgen-1000689-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000689.g004</object-id><label>Figure 4</label><caption><title>Control of <italic>glpFK</italic> operon promoter activity.</title><p>(A) Effects of IS5, promoter-less IS5 and IB on expression of the downstream <italic>glpFK</italic> promoter in <italic>crp</italic> cells. &#x02018;IS&#x02019;, &#x02018;P-less&#x02019;, &#x02018;IB&#x02019;, &#x02018;178&#x02019;, &#x02018;none&#x02019;, and &#x02018;IBZ&#x02019; refer to transcriptional <italic>lacZ</italic> fusions for IS5:P<italic>glpFK</italic>, promoter-less IS5:P<italic>glpFK</italic>, IB:P<italic>glpFK</italic>, 178 bp:P<italic>glpFK</italic>, native P<italic>glpFK</italic>, and IB alone, respectively (see <xref ref-type="fig" rid="pgen-1000689-g001">Figure 1A</xref>). (B) IB:P<italic>glpFK</italic> activity in <italic>wt</italic>, <italic>crp</italic>, <italic>glpR</italic> and <italic>crp glpR</italic> cells. In both A and B, wild-type and mutant cells were grown with shaking in LB with or without 1&#x00025; glycerol (Gly) or 1&#x00025; glucose (Glu). (C) Effect of a 5- or 10-oligonucleotide insertion between IB and P<italic>glpFK</italic> on promoter activity. A 5 bp (TACCT) or a 10 bp (<named-content content-type="gene">TACCTTACCT</named-content>) fragment was inserted between &#x02212;117 and &#x02212;118 relative to &#x0002b;1 of P<italic>glpFK</italic> (see <xref ref-type="fig" rid="pgen-1000689-g001">Figure 1B</xref>). &#x003b2;-Galactosidase activities of these promoters were measured in <italic>crp</italic> and <italic>crp glpR</italic> cells grown in minimal M9 medium &#x0002b; 0.66&#x00025; casamino acids (CAA) &#x0002b; 1&#x00025; glucose. &#x02018;IB&#x02019;, &#x02018;IB:5&#x02019;, &#x02018;IB:10&#x02019;, and &#x02018;none&#x02019; refer to IB:P<italic>glpFK</italic>, IB:5 bp:P<italic>glpFK</italic>, IB:10 bp:P<italic>glpFK</italic> and P<italic>glpFK</italic> alone, respectively.</p></caption><graphic xlink:href="pgen.1000689.g004"/></fig><p>Addition of glycerol to LB medium further increased the promoter activity, in agreement with the conclusion that GlpR weakly decreased IS5:P<italic>glpFK</italic> activity. The increased level (&#x0223c;1.5 fold) of P<italic>glpFK</italic> activity caused by the presence of glycerol in a <italic>crp</italic> genetic background, measured by &#x003b2;-galactosidase activity in a <italic>glpF</italic>-<italic>lacZ</italic> fusion strain, was lower than that observed (&#x0223c;2.5 fold) for <italic>glpFK</italic> mRNA in a <italic>crp</italic> Glp<sup>&#x0002b;</sup> background (<xref ref-type="fig" rid="pgen-1000689-g002">Figure 2A</xref>). Such a difference may be due to the fact that <italic>crp</italic> Glp<sup>&#x0002b;</sup> cells transport and subsequently phosphorylate glycerol more rapidly than <italic>crp</italic> cells. Addition of glucose to the medium slightly reduced the activities of the promoters tested, showing that the strong catabolite repression observed in the wild type strain was largely abolished. Further experiments reported below confirmed and extended this conclusion.</p><p>IB:P<italic>glpFK-lacZ</italic> activity was subsequently characterized in other genetic backgrounds. High levels of &#x003b2;-galactosidase activity were observed for <italic>wt</italic>, <italic>crp</italic>, <italic>glpR</italic> and <italic>crp glpR</italic> genetic backgrounds with cells grown in LB &#x000b1; glycerol or &#x000b1; glucose (<xref ref-type="fig" rid="pgen-1000689-g004">Figure 4B</xref>). Similar levels of promoter activity were observed in <italic>wt</italic> and <italic>crp</italic> cells in the absence of glycerol, suggesting that the Crp protein does not appreciably influence IB:P<italic>glpFK</italic> activity. Addition of glycerol increased the overall IB:P<italic>glpFK</italic> activity by &#x0223c;2 fold in <italic>wt</italic> cells (column 1 and column 5 in <xref ref-type="fig" rid="pgen-1000689-g004">Figure 4B</xref>) and &#x0223c;1.3 fold in <italic>crp</italic> cells (columns 2 and 6 in <xref ref-type="fig" rid="pgen-1000689-g004">Figure 4B</xref>), while addition of glucose slightly decreased it. Higher promoter activities were detected in <italic>glpR</italic> and <italic>crp glpR</italic> cells than in <italic>wt</italic> and <italic>crp</italic> cells, respectively, in the absence of glycerol. Addition of glycerol did not further increase these activities in cells containing the <italic>glpR</italic> mutation (columns 4 and 8). However, in the absence of GlpR, deletion of the <italic>crp</italic> gene reduced the activating effect of IB by about 20&#x00025; (<xref ref-type="fig" rid="pgen-1000689-g004">Figure 4B</xref>). It is possible that Crp positively influences the expression of a gene encoding a protein such as IHF, which is required for full activation of P<italic>glpFK</italic> by IB. The role of Crp in IB activation of P<italic>glpFK</italic> thus appears to be minimal, but it could be indirect and complex.</p><p>As a control, a 178 bp internal fragment of IS5 (nucleotides 226 to 403 from its 5&#x02032; end), similar in length to that of IB (177 bps), was substituted for IB in IB:P<italic>glpFK</italic>, and the activity of the construct (178bp:P<italic>glpFK</italic>) was determined in <italic>crp</italic> cells. &#x003b2;-Galactosidase activity was not increased compared to P<italic>glpFK</italic> alone (<xref ref-type="fig" rid="pgen-1000689-g004">Figure 4A</xref>). Another control showed that IB alone in front of <italic>lacZ</italic> (IB-<italic>lacZ</italic>) had no promoter activity regardless of the medium used (<xref ref-type="fig" rid="pgen-1000689-g004">Figure 4A</xref>). The results presented in <xref ref-type="fig" rid="pgen-1000689-g004">Figure 4A and 4B</xref> together show that the stimulation of P<italic>glpFK</italic> activity mediated by IS5 insertion is due to the IB segment (i.e., the 177 bases located at the 3&#x02032;-end of IS5). Such activation is so strong that (1) Crp is not required and (2) GlpR only weakly represses.</p><p>To further show that the transposase, encoded by <italic>ins5A</italic> (981 bp) <xref ref-type="bibr" rid="pgen.1000689-Kroger1">&#x0005b;22&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000689-Rak1">&#x0005b;23&#x0005d;</xref>, is not involved in IS5 activation, IS5:P<italic>glpFK-lacZ</italic>, promoter-less IS5:P<italic>glpFK-lacZ</italic>, IB:P<italic>glpFK-lacZ</italic>, P<italic>glpFK</italic>-<italic>lacZ</italic> and 178 bp:P<italic>glpFK</italic>-<italic>lacZ</italic> fusions were individually moved to a <italic>crp</italic> mutant background of <italic>E. coli</italic> strain B which lacks IS5 <xref ref-type="bibr" rid="pgen.1000689-Schneider1">&#x0005b;24&#x0005d;</xref>. Similar to BW25113 <italic>crp</italic> cells, IS5 and IB equally elevated promoter activity in strain B <italic>crp</italic> cells compared to P<italic>glpFK</italic> alone (<xref ref-type="supplementary-material" rid="pgen.1000689.s002">Figure S2</xref>). The 178-bp IS5 internal fragment was unable to activate P<italic>glpFK</italic> in these IS5-free <italic>crp</italic> cells. This experiment clearly demonstrates that the transposase does not contribute to IS5 activation of P<italic>glpFK</italic>. It is IB, the 3&#x02032; end region of IS5 that activates P<italic>glpFK</italic> in the absence of Crp.</p></sec><sec id="s2d"><title>Effect of IB Positioning on the Activity of IB:P<italic>glpFK</italic></title><p>To determine if IB activation of P<italic>glpFK</italic> is DNA phase dependent, two oligonucleotide sequences (5 bp and 10 bp) were individually inserted at &#x02212;117.5 (relative to &#x0002b;1 of P<italic>glpFK</italic>) between IB and P<italic>glpFK</italic> (<xref ref-type="fig" rid="pgen-1000689-g001">Figure 1</xref>). As shown in <xref ref-type="fig" rid="pgen-1000689-g004">Figure 4C</xref>, insertion of a 5 bp nucleotide sequence almost completely abolished promoter activity in both <italic>crp</italic> and <italic>crp glpR</italic> cells although insertion of a 10 bp oligonucleotide sequence only slightly reduced promoter activity. These results indicate that the proper positioning of the upstream IB relative to P<italic>glpFK</italic> is essential for full promoter activation in <italic>crp</italic> cells. They are consistent with a requirement for a 10 bp periodicity in the position of the insert for strong stimulation as expected for B-DNA. The latter implies the involvement of DNA structure (e.g., bending or looping) in P<italic>glpFK</italic> activation by IB. These results were obtained for both IB and IS5 (data not shown).</p></sec><sec id="s2e"><title>Requirement of IHF and the IHF Binding Site in IB for Full Activation of P<italic>glpFK</italic></title><p>As demonstrated above, the IB segment has the same ability as the intact IS5 to activate P<italic>glpFK</italic> in the <italic>crp</italic> genetic background. A putative IHF binding site is present in the middle of IB <xref ref-type="bibr" rid="pgen.1000689-Muramatsu1">&#x0005b;25&#x0005d;</xref>. To determine if the host IHF protein plays a role in activation of P<italic>glpFK</italic>, we generated a null <italic>ihfA</italic> mutant in <italic>wt</italic> and <italic>crp</italic> Glp<sup>&#x0002b;</sup> backgrounds. These mutant strains were compared for growth in M9 minimal medium with glycerol as the sole carbon source (<xref ref-type="fig" rid="pgen-1000689-g005">Figure 5A</xref>). No obvious difference in growth was found between <italic>wt</italic> and <italic>ihfA</italic> mutant cells. However, growth of <italic>crp</italic> Glp<sup>&#x0002b;</sup> cells was substantially reduced by the <italic>ihfA</italic> mutation.</p><fig id="pgen-1000689-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000689.g005</object-id><label>Figure 5</label><caption><title>Dependency of <italic>glpFK</italic> promoter activation on IHF binding to IB (A&#x02013;C) as well as the A-tract-promoting permanent bend in IB (D).</title><p>(A) Growth of <italic>crp</italic> Glp<sup>&#x0002b;</sup> (&#x02022;), <italic>ihfA</italic> (&#x003c3;) and <italic>crp</italic> Glp<sup>&#x0002b;</sup><italic>ihfA</italic> (&#x02592;) cells in liquid glycerol (1&#x00025;) M9 minimal medium. (B) Effect of a host <italic>ihfA</italic> null mutation on IB:P<italic>glpFK</italic> activity. (C) Effect of IHF binding site mutations in IB on IB:P<italic>glpFK</italic> activity. &#x02018;None&#x02019;, &#x02018;single&#x02019;, and &#x02018;double&#x02019; refer to no mutation, mutation of TCAA (&#x02212;221 to &#x02212;218 relative to &#x0002b;1 of P<italic>glpFK</italic>) to GTCT, and mutation of TCAA to GTCT as well as TT (&#x02212;213 to &#x02212;212) to GC in the IHF binding site located in IB, respectively (see <xref ref-type="fig" rid="pgen-1000689-g001">Figure 1B</xref>). (D) <italic>lacZ</italic> expression measured by &#x003b2;-galactosidase assay for <italic>crp</italic> cells carrying an IB:P<italic>glpFK</italic>-<italic>lacZ</italic> fusion with various A-tract mutations in IB. The strain bearing altered A-tracts 4&#x02013;8 includes the mutations shown in A-tracts 4&#x02013;8. &#x02018;none&#x02019;, &#x02018;A-tracts 4&#x02013;8&#x02019;, &#x02018;A-tract 3&#x02019; and &#x02018;A-tracts 1&#x02013;3&#x02019; refer to no mutation, mutations in A-tracts 4 to 8, mutation in A-tract 3 and mutations in A-tracts 1 to 3, respectively (see <xref ref-type="fig" rid="pgen-1000689-g001">Figure 1B</xref>).</p></caption><graphic xlink:href="pgen.1000689.g005"/></fig><p>To determine the effect of the loss of IHF on transcription of IB:P<italic>glpFK</italic>, an IB:P<italic>glpFK</italic>-<italic>lacZ</italic> fusion was transferred into a <italic>crp ihfA</italic> double mutant genetic background by P1 transduction. &#x003b2;-Galactosidase assays were performed after growing cells in LB media with or without glycerol or glucose. As shown in <xref ref-type="fig" rid="pgen-1000689-g005">Figure 5B</xref>, the activity of IB:P<italic>glpFK</italic> was reduced &#x0223c;60&#x00025; by the loss of IHF. Similar results were obtained when M9 &#x0002b; casamino acids &#x0002b; glucose medium was used (data not shown). These results are consistent with the growth data described above and indicate that IHF is required for maximal activation of P<italic>glpFK</italic> by the IB segment.</p><p>To determine if the putative IHF binding site in IB is responsible for IHF-mediated activation, we mutated the site as follows (see <xref ref-type="fig" rid="pgen-1000689-g001">Figure 1A</xref>): (1) TCAA (&#x02212;218 to &#x02212;221, relative to &#x0002b;1 of P<italic>glpFK</italic>) to GTCT (single mutation) and (2) TCAA to GTCT together with TT (&#x02212;212 to &#x02212;213) to GC (double mutations). The activities of the IB:P<italic>glpFK</italic> constructs with any one of these mutated IHF binding sites were determined using transcriptional <italic>lacZ</italic> fusions (<xref ref-type="fig" rid="pgen-1000689-g005">Figure 5C</xref>). When cells were grown in minimal or LB medium, these alterations resulted in 50&#x02013;60&#x00025; reductions in the activity of IB:P<italic>glpFK</italic> compared to the parental construct. These results clearly indicate that the IHF binding site in the middle of IB is required for activation of P<italic>glpFK</italic> by the host IHF protein.</p><p>To determine if an IHF binding site alone is capable of stimulating the activity of the <italic>glpFK</italic> promoter, an IHF binding site was introduced upstream of P<italic>glpFK</italic> by changing gccttgcagatta (&#x02212;222 to &#x02212;210 relative to &#x0002b;1 of P<italic>glpFK</italic>) to aatcaagcagtta (<xref ref-type="supplementary-material" rid="pgen.1000689.s003">Figure S3A</xref>). The newly created site was at the same distance as that of the IHF site in IB:P<italic>glpFK</italic> relative to the promoter (<xref ref-type="fig" rid="pgen-1000689-g001">Figure 1B</xref> and <xref ref-type="supplementary-material" rid="pgen.1000689.s003">Figure S3A</xref>). Using a chromosomal <italic>lacZ</italic> fusion, the activity of P<italic>glpFK</italic> containing this upstream IHF binding site was examined in <italic>wt</italic> and <italic>crp</italic> cells grown in LB medium. The promoter activity was increased by &#x0223c;40&#x00025; in <italic>wt</italic> cells but was not changed in <italic>crp</italic> cells (<xref ref-type="supplementary-material" rid="pgen.1000689.s003">Figure S3B</xref>). These results show that (1) IHF can bind to the created binding site; (2) the binding of IHF is capable of partially stimulating P<italic>glpFK</italic> activity but only in the presence of Crp; and (3) IHF stimulation of IB:P<italic>glpFK</italic> in the absence of Crp is dependent not only on the IHF binding site present in IB but also on the adjacent sequences (e.g., the A-tracts) surrounding the site.</p></sec><sec id="s2f"><title>Dependency of <italic>glpFK</italic> Operon Activation on the Permanent Bend in IS5</title><p>A characteristic of a permanent DNA bend is the presence of in-phase A-tracts of 3&#x02013;6 tandem As. The permanent bend in the IB region of IS5 has been shown to be one of the largest bend angles in the <italic>E. coli</italic> chromosome <xref ref-type="bibr" rid="pgen.1000689-Muramatsu1">&#x0005b;25&#x0005d;</xref>.</p><p>To examine the dependency of <italic>glpFK</italic> expression in a <italic>crp</italic> Glp<sup>&#x0002b;</sup> genetic background on the A-tracts in the IB region of IS5, three different sets of mutated A-tracts were constructed by changing specific As in these tracts to Cs or Gs (see <xref ref-type="fig" rid="pgen-1000689-g001">Figure 1A</xref>). The mutated strains were then examined for expression using a P<italic>glpFK</italic>-<italic>lacZ</italic> reporter gene fusion. All three sets of A-tract mutations lowered the expression level. However, mutating the five upstream A-tracts (A-tracts 4&#x02013;8, see <xref ref-type="fig" rid="pgen-1000689-g001">Figure 1A</xref>) had a minimal effect on expression (<xref ref-type="fig" rid="pgen-1000689-g005">Figure 5D</xref>). Mutation of A-tract 3 only (A-tract 3) also had a minimal effect. However, mutational alteration of three consecutive A-tracts in the downstream region (A-tracts 1&#x02013;3) had a dramatic effect on gene expression. From these observations and those reported in the previous section, we conclude that (i) the downstream permanent bend is important for gene activation, (ii) the upstream A-tract region is of minimal importance for gene expression, and (iii) IHF binding and the three downstream A-tracts are roughly of equal importance. We can therefore account for IS5 activation of <italic>glpFK</italic> operon expression by IHF binding and the downstream A-tracts which apparently activate gene expression in an additive fashion, probably by bending the DNA.</p><p>To confirm the importance of both the A-tracts and the IHF binding site in IB to IS5 activation of P<italic>glpFK</italic>, the IB:P<italic>glpFK</italic>-<italic>lacZ</italic> fusion containing mutations in A-tracts 1&#x02013;3 in IB was transferred into the <italic>ihfA</italic> genetic background. As shown in <xref ref-type="supplementary-material" rid="pgen.1000689.s004">Figure S4</xref>, promoter activity was completely abolished. This experiment therefore shows that the activating effects of IHF and the downstream permanent bend are responsible for promoter activation, and that these two effects are additive.</p><p>As shown above, when the upstream 47 bps in the 177 bp fragment (IB) were deleted, 60&#x00025; of the activation was retained. When the upstream A-tracts were disrupted by point mutations, 85&#x00025; of the activation was retained (<xref ref-type="fig" rid="pgen-1000689-g005">Figure 5D</xref>). There may therefore be a mild dependency of activation on these upstream sequences, but we do not know exactly why this difference was observed. Possibly, deletion of this upstream region has an indirect contextual effect on the downstream region that plays a dominant role in <italic>glpFK</italic> promoter activation.</p></sec><sec id="s2g"><title>Effects of IS5 and IB on the Activity of the <italic>lacZYA</italic> Promoter (P<italic>lac</italic>)</title><p>To determine if IB can activate a different Crp-dependent promoter in a <italic>crp</italic> genetic background, IB was placed at positions &#x02212;126.5 (the same relative position as in IB:P<italic>glpFK</italic>) and &#x02212;178.5 (relative to &#x0002b;1 of P<italic>lac</italic>) upstream of P<italic>lac</italic>, yielding IB:P<italic>lac</italic> and IB:P<italic>lac</italic>', respectively. These two sites differ by 22 bps, are therefore should be in phase. The difference in activation of P<italic>lac</italic> would presumably reflect the distance from the activated promoter.</p><p>Using chromosomal <italic>lacZ</italic> fusions, the activities of these constructs were examined in both <italic>crp</italic> and <italic>crp lacI</italic> cells grown in M9 medium &#x0002b; 0.66&#x00025; casamino acids &#x0002b;1&#x00025; glucose (<xref ref-type="fig" rid="pgen-1000689-g006">Figure 6A</xref>). In the absence of IPTG, no appreciable activity was observed for P<italic>lac</italic> with or without the upstream IB sequence in <italic>crp</italic> cells (columns 1&#x02013;3 of <xref ref-type="fig" rid="pgen-1000689-g006">Figure 6A</xref>). However, in the presence of IPTG, IB increased the P<italic>lac</italic> activity 8 fold when it was located at &#x02212;126.5, and 2 fold when it was located at &#x02212;178.5 compared to P<italic>lac</italic> alone (columns 7&#x02013;9 of <xref ref-type="fig" rid="pgen-1000689-g006">Figure 6A</xref>). These two positions are in phase assuming 10.5 bp per turn in DNA. We also measured the activities of IB:P<italic>lac</italic> and IB:P<italic>lac</italic>' in <italic>crp lacI</italic> double mutant cells. As expected, regardless of the presence of IPTG, they behaved similarly as in <italic>crp</italic> cells with IPTG (i.e., 8 and 2 fold increased activation for IB:P<italic>lac</italic> and IB:P<italic>lac</italic>', respectively). The entire IS5 element showed the same ability as the IB element to activate P<italic>lac</italic> (data not shown). These results indicate that (i) IS5 or IB can at least partially replace the function of Crp in activating P<italic>lac</italic>; (ii) a proper location of these fragments is important for activation of gene expression in the absence of Crp; and (iii) in contrast to the <italic>glpFK</italic> system, activation is fully blocked by operator-bound LacI.</p><fig id="pgen-1000689-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000689.g006</object-id><label>Figure 6</label><caption><title>Effects of IB and its location on the activity of the <italic>lacZYA</italic> promoter (P<italic>lac</italic>).</title><p>(A) Effect on P<italic>lac</italic> in the absence of Crp. (B) Effect on P<italic>lac</italic> in the presence of Crp. <italic>crp</italic>, <italic>crp lacI</italic>, and <italic>wt</italic> cells were grown in M9 minimal medium &#x0002b; 0.66&#x00025; CAA &#x0002b; 1&#x00025; glucose without or with IPTG (200 &#x000b5;M). In IB:P<italic>lac</italic> and IB:P<italic>lac</italic>', IB is located at &#x02212;126.5 (the same relative position as in IB:P<italic>glpFK</italic>) and &#x02212;178.5 upstream of the <italic>lacZ</italic> transcriptional start site, respectively.</p></caption><graphic xlink:href="pgen.1000689.g006"/></fig><p>We further measured IB effects on P<italic>lac</italic> activity in wild type (<italic>crp</italic><sup>&#x0002b;</sup>) cells grown in the same M9 minimal medium as above. In the absence of IPTG, the activities of P<italic>lac</italic> with or without the upstream IB were extremely low (20 Miller units or less) (Columns 1, 3 and 4 of <xref ref-type="fig" rid="pgen-1000689-g006">Figure 6B</xref>). In the presence of IPTG, IB increased the <italic>lac</italic> promoter activity &#x0223c;2.5 fold when it was located at &#x02212;126.5 compared to the <italic>lac</italic> promoter alone. No increased P<italic>lac</italic> activity was observed when IB was located at &#x02212;178.5 upstream of the promoter. These results indicate that (i) LacI still blocks the activation of P<italic>lac</italic> by both Crp and IB, and (ii) when present at an appropriate position, IB is still capable of enhancing the activity of P<italic>lac</italic> in the presence of Crp. In other words, IB and Crp activate P<italic>lac</italic> in an additive fashion. This is different from IB activation of P<italic>glpFK</italic>, in which case, the presence of Crp did not further elevate the activity of IB:P<italic>glpFK</italic> (see <xref ref-type="fig" rid="pgen-1000689-g004">Figure 4B</xref>).</p></sec></sec><sec id="s3"><title>Discussion</title><p>We have demonstrated that a transposon, IS5, is capable of activation of the <italic>glpFK</italic> operon, rendering <italic>E. coli</italic> cells capable of utilizing glycerol in the absence of Crp. Transposable elements have been found to activate transcription of adjacent genes by introducing complete or partial promoters located within the element or by disrupting or displacing a negative element that normally blocks transcription <xref ref-type="bibr" rid="pgen.1000689-Chandler1">&#x0005b;3&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000689-Mahillon1">&#x0005b;4&#x0005d;</xref>. The mechanism of <italic>glpFK</italic> activation by IS5 is distinct from these reported mechanisms. In this case, a part of IS5, which is proximal to the adjacent gene and harbors unique sequences (A-tracts and an IHF binding site), can functionally replace Crp and directly activate the native downstream promoter.</p><p>Prior to the work reported here, the best-characterized example of transposon-mediated gene activation was of the &#x003b2;-glucoside (<italic>bgl</italic>) operon in <italic>E. coli</italic> (see <xref ref-type="sec" rid="s1">Introduction</xref>) <xref ref-type="bibr" rid="pgen.1000689-Reynolds1">&#x0005b;8&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pgen.1000689-Mukerji1">&#x0005b;12&#x0005d;</xref>. This system shows the following characteristics: 1) The <italic>bgl</italic> operon is not active in wild-type <italic>E. coli</italic>. 2) Either IS1 or IS5 can activate <italic>bgl</italic> operon expression. 3) When it is activated, <italic>bgl</italic> expression is subject to catabolite control by Crp as well as inducer sensitivity by an anti-termination mechanism. 4) Activation by the IS element occurs by an enhancer-type mechanism. 5) The IS element can activate when either upstream or downstream of the promoter, and in either orientation. 6) Activation is at least partially dependent on the IS-encoded transposase. 7) Activation is dependent on relief of repression by H-NS. 8) Although the most frequent mechanism for activation involves insertion sequence elements, activation can also be caused by mutations in <italic>gyrA</italic> or <italic>gyrB</italic><xref ref-type="bibr" rid="pgen.1000689-DiNardo1">&#x0005b;26&#x0005d;</xref>, <italic>hns</italic><xref ref-type="bibr" rid="pgen.1000689-Higgins1">&#x0005b;27&#x0005d;</xref>, <italic>bglJ</italic><xref ref-type="bibr" rid="pgen.1000689-Giel1">&#x0005b;28&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000689-Stratmann1">&#x0005b;29&#x0005d;</xref>, <italic>leuO</italic><xref ref-type="bibr" rid="pgen.1000689-Lopilato1">&#x0005b;30&#x0005d;</xref> or the Crp binding site of the <italic>bgl</italic> promoter <xref ref-type="bibr" rid="pgen.1000689-Ueguchi1">&#x0005b;31&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000689-Reynolds2">&#x0005b;32&#x0005d;</xref>.</p><p>In all of these respects, activation of <italic>glpFK</italic> appears to differ from that of the <italic>bgl</italic> operon: 1) The <italic>glpFK</italic> operon is active in wild-type <italic>E. coli</italic>. 2) Only IS5 has been observed to activate <italic>glpFK</italic> operon expression in a <italic>crp</italic> genetic background. 3) Once activated, the operon is expressed independently of Crp and largely independently of the <italic>glp</italic> regulon repressor, GlpR. 4) There is no evidence that IS5 acts on P<italic>glpFK</italic> by an enhancer-type mechanism. 5) Only a single site of insertion and only one orientation were demonstrated, and this site proved to be the IS5 tetranucleotide target sequence, CTAA, located at a specific position upstream of the promoter. 6) Activation is independent of the IS5-encoded transposase. 7) IHF, but not H-NS, is required for maximal gene activation. 8) Except for IS5 insertion, no other mutations have been identified to account for activation of <italic>glpFK</italic> expression.</p><p>We identified a short sequence in IS5 (IB) that is fully responsible for P<italic>glpFK</italic> activation. This sequence includes a permanent bend and an IHF binding site. An IHF binding site has been found to be present in the ends of the IS1 element, but several lines of evidence have shown that this IHF site does not play a role in gene activation although it bends the DNA <xref ref-type="bibr" rid="pgen.1000689-Prentki1">&#x0005b;33&#x0005d;</xref>. In the present study, we showed that the IHF binding site in IS5 plays an important role since an <italic>ihfA</italic> null mutation or alteration of the IHF binding site partially abolished activation to the same degree. No function for the IB region had been recognized prior to our studies. It may have evolved specifically for the purpose of gene activation, for another unrecognized purpose, or for both.</p><p>We further showed that DNA phasing is important since the insertion of 5 bps (but not 10 bps) between the activating element and P<italic>glpFK</italic> abolished activation. Preliminary evidence suggested that the C-terminal domain of the &#x003b1;-subunit of RNA polymerase is not required for activation (unpublished results), but a DNA looping mechanism is nevertheless proposed.</p><p>The activating IB region contains as many as 10 A-tracts, which in general can induce permanent bends in DNA (see <xref ref-type="fig" rid="pgen-1000689-g005">Figure 5D</xref>) <xref ref-type="bibr" rid="pgen.1000689-Muramatsu1">&#x0005b;25&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000689-Koo1">&#x0005b;34&#x0005d;</xref> and can increase promoter activity <xref ref-type="bibr" rid="pgen.1000689-Aiyar1">&#x0005b;35&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000689-Bracco1">&#x0005b;36&#x0005d;</xref>. In one case, transcriptional activation involves binding of the DNA to the C-terminal domain of the RNA polymerase &#x003b1;-subunit (35). In view of our results, it seems likely that the permanent bend in the downstream region of IS5 together with bound IHF activates <italic>glpFK</italic> promoter activity at least in part by bending the upstream DNA. A direct interaction of IHF with the transcriptional initiation complex is possible <xref ref-type="bibr" rid="pgen.1000689-Giladi1">&#x0005b;37&#x0005d;</xref>.</p><p>Although this is the first study to show that unique sequences inside a transposon are necessary and sufficient to activate a downstream silent promoter, similar mechanisms of gene activation may occur for other operons (see <xref ref-type="fig" rid="pgen-1000689-g006">Figure 6</xref> and unpublished results). These include the <italic>lacZYA</italic>, <italic>fucAO</italic> and <italic>flhDC</italic> operons <xref ref-type="bibr" rid="pgen.1000689-Chen1">&#x0005b;13&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000689-Barker1">&#x0005b;14 and observations reported here&#x0005d;</xref>. On the other hand, the isolation and analysis of mutations that allow <italic>E. coli crp</italic> mutants to grow on several other Crp-dependent carbon sources <xref ref-type="bibr" rid="pgen.1000689-Gosset1">&#x0005b;38&#x0005d;</xref> indicate that IS-mediated gene activation is not the only mechanism available to <italic>E. coli</italic>. We propose that IS5 insertion under the control of a host regulatory protein represents just one of many mechanisms of operon adaptive activation that will prove to occur under stressful conditions.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Bacterial Strains and Growth Conditions</title><p>Strains and oligonucleotides used in this study are described in <xref ref-type="supplementary-material" rid="pgen.1000689.s005">Table S1</xref> and <xref ref-type="supplementary-material" rid="pgen.1000689.s006">Table S2</xref>, respectively. The <italic>crp</italic>, <italic>glpR</italic>, <italic>crp</italic> Glp<sup>&#x0002b;</sup> and <italic>crp glpR</italic> Glp<sup>&#x0002b;</sup> mutants, derived from <italic>E. coli</italic> K-12 strain BW25113, were constructed previously <xref ref-type="bibr" rid="pgen.1000689-Zhang1">&#x0005b;21&#x0005d;</xref>. The <italic>crp lacI</italic> double mutant was made by transferring the <italic>lacI</italic> insertion mutation from MG1655 <xref ref-type="bibr" rid="pgen.1000689-Kuhlman1">&#x0005b;39&#x0005d;</xref> to a BW25115 <italic>crp</italic> deletion background using P1 transduction. The <italic>hns</italic> and <italic>ihfA</italic> isogenic deletion mutant was derived from the same <italic>wt</italic> strain BW25113 using the method of Datsenko and Wanner <xref ref-type="bibr" rid="pgen.1000689-Datsenko1">&#x0005b;40&#x0005d;</xref>. Double and triple mutants, <italic>crp hns</italic>, <italic>crp</italic> Glp<sup>&#x0002b;</sup><italic>hns</italic>, <italic>crp ihfA</italic> and <italic>crp</italic> Glp<sup>&#x0002b;</sup><italic>ihfA</italic>, were made by P1 transduction. The detailed procedures for generating single or double mutants are described in the reference 21. Strain BW25113 is deleted for the <italic>lacZ</italic> gene and the <italic>araBAD</italic> operon encoding proteins required for L-arabinose metabolism <xref ref-type="bibr" rid="pgen.1000689-Datsenko1">&#x0005b;40&#x0005d;</xref>. All mutants were verified by PCR. The strains were cultured in LB or minimal M9 media with various carbon sources at 37&#x000b0;C or 30&#x000b0;C. When appropriate, kanamycin (Km; 25 &#x000b5;g/ml), or ampicillin (Ap; 100 &#x000b5;g/ml) was added to the media.</p></sec><sec id="s4b"><title>Glycerol Kinase Activity Assay</title><p>The activity of glycerol kinase encoded by <italic>glpK</italic> was determined using &#x0005b;1,3-<sup>14</sup>C&#x0005d;glycerol as substrate. Cells were cultured in LB with or without 1&#x00025; glycerol, and cellular extracts were prepared using a French press and the subsequent ultracentrifugation. Glycerol phosphorylation by GlpK in the extracts was quantitated as described previously <xref ref-type="bibr" rid="pgen.1000689-Aboulwafa1">&#x0005b;41&#x0005d;</xref>.</p></sec><sec id="s4c"><title>Site-Directed Mutagenesis</title><p>Using the quick-change site-directed mutagenesis kit (Stratagene), the following modifications were made in IS5, its IB region or the <italic>glpFK</italic> promoter region: (i) removal of the <italic>EcoR</italic>I site in IS5 by changing A (135 bp from the 5&#x02032; end) to G; (ii) insertion of a 5-bp (tacct) or a 10-bp (taccttacct) oligonucleotide at &#x02212;117.5 (relative to &#x0002b;1 of P<italic>glpFK</italic>) in the IB:P<italic>glpFK</italic> junctional region (see <xref ref-type="fig" rid="pgen-1000689-g001">Figure 1B</xref>); (iii) mutation of the IHF binding site in IB by changing TCAA to GTCT (&#x02212;221 to &#x02212;218, relative to &#x0002b;1 of P<italic>glpFK</italic>) and TT (&#x02212;213 to &#x02212;212, relative to &#x0002b;1 of P<italic>glpFK</italic>) to GC (see <xref ref-type="fig" rid="pgen-1000689-g001">Figure 1B</xref>); iv) mutations of individual or multiple A-tracts in IB by changing one or two As to Cs or Gs (see <xref ref-type="fig" rid="pgen-1000689-g001">Figure 1B</xref>). All the mutation primers are listed in <xref ref-type="supplementary-material" rid="pgen.1000689.s006">Table S2</xref>. Sequence alterations were confirmed by DNA sequencing.</p></sec><sec id="s4d"><title>Real Time (RT) PCR</title><p>RT-PCR was performed as described previously <xref ref-type="bibr" rid="pgen.1000689-Zhang2">&#x0005b;42&#x0005d;</xref>. Cells were grown in LB with or without 1&#x00025; glycerol. Total RNA was prepared using an EZgene&#x02122; RNA purification kit (Biomiga). The contaminated chromosomal DNA in RNA samples was removed by DNase I treatment. cDNAs were synthesized using an Invitrogen superscript first-strand synthesis kit. <italic>polA</italic>, encoding DNA polymerase I, was included as an internal control <xref ref-type="bibr" rid="pgen.1000689-McHugh1">&#x0005b;43&#x0005d;</xref>. Primers used for RT-PCR are listed in <xref ref-type="supplementary-material" rid="pgen.1000689.s006">Table S2</xref>. RT-PCR was carried out with a LightCycler instrument (Roche).</p></sec><sec id="s4e"><title>Chromosomal <italic>lacZ</italic> Fusions and &#x003b2;-Galactosidase Assays</title><p>The <italic>glpFK</italic> promoter region (&#x02212;203 to &#x0002b;67 relative to the transcriptional start site), with or without the upstream IS5 element or part of the IS5 element, was PCR amplified from the chromosome of <italic>crp</italic> or <italic>crp</italic> Glp<sup>&#x0002b;</sup> cells. The PCR products were digested with <italic>BamH</italic>I and <italic>EcoR</italic>I, gel purified using an EZgene&#x02122; gel purification kit (Biomiga), and then ligated into the same sites of pRS551 <xref ref-type="bibr" rid="pgen.1000689-Simons1">&#x0005b;44&#x0005d;</xref>. Transcriptional <italic>lacZ</italic> fusions present in the pRS551 plasmids were integrated into the lambda attachment site (<italic>attB</italic>) in the <italic>E. coli</italic> chromosome using the method of Simons et al. <xref ref-type="bibr" rid="pgen.1000689-Simons1">&#x0005b;44&#x0005d;</xref>. P1 transduction was used to transfer a chromosomal promoter:<italic>lacZ</italic> fusion from one strain to another strain.</p><p>To add an IHF binding site upstream of the <italic>glpFK</italic> promoter at the same relative distance as in IB:P<italic>glpFK</italic>, a separate P<italic>glpFK</italic> (&#x02212;220 to &#x0002b;67) was amplified from the <italic>wt</italic> chromosome using primers PglpFK_IHF-F and PglpFK-R1 (<xref ref-type="supplementary-material" rid="pgen.1000689.s006">Table S2</xref>). An IHF binding site (aatcaagcagtta) was present at the 5&#x02032; end of primer PglpFK_IHF-F. The PCR products that contained the IHF binding site were fused to a promoter-less <italic>lacZ</italic> gene, and the resultant transcriptional promoter:<italic>lacZ</italic> fusion was moved to the chromosome as described above (see <xref ref-type="supplementary-material" rid="pgen.1000689.s003">Figure S3</xref>).</p><p>To make chromosomal P<italic>lac</italic>-<italic>lacZ</italic>, P<italic>lacZYA</italic> (&#x02212;126 to &#x0002b;38 or &#x02212;178 to &#x0002b;38) was first cloned into the <italic>BamH</italic>I and <italic>EcoR</italic>I sites of pRS551. The entire IS5 or IB was inserted into the <italic>BamH</italic>I site of the plasmid so that IS5 or IB was located at &#x02212;126.5 or &#x02212;178.5, relative to &#x0002b;1 of P<italic>lacZYA</italic>. The fusions of P<italic>lac</italic> with or without IS5 or IB to <italic>lacZ</italic> were integrated to the chromosome of <italic>crp</italic> cells. Primers used for RT-PCR and <italic>lacZ</italic> fusion construction are listed in <xref ref-type="supplementary-material" rid="pgen.1000689.s006">Table S2</xref>.</p><p>&#x003b2;-Galactosidase assays, conducted after growth in either LB or M9 minimal media &#x000b1; 1&#x00025; glycerol, 1&#x00025; glucose or 0.66&#x00025; casamino acids (CAA), were as described by Miller <xref ref-type="bibr" rid="pgen.1000689-Miller1">&#x0005b;45&#x0005d;</xref>. CAA was added to improve growth of <italic>crp</italic> cells in minimal media.</p></sec><sec id="s4f"><title>RNA Ligase Mediated PCR</title><p>RNA ligase mediated PCR was used to determine the transcriptional start site of the <italic>glpFK</italic> operon as described by Bensing et al. <xref ref-type="bibr" rid="pgen.1000689-Bensing1">&#x0005b;46&#x0005d;</xref>. Cells were grown in LB with or without 1&#x00025; glycerol. The total RNA was prepared using a Biomiga RNA purification kit and treated with or without tobacco acid pyrophosphatase (TAP). The RNA oligonucleotide adaptor (<xref ref-type="supplementary-material" rid="pgen.1000689.s006">Table S2</xref>) was ligated to all RNAs, and the 5&#x02032;-end of the <italic>glpFK</italic> cDNA was synthesized using an oligonucleotide (PglpFK-extn-R) complementary to nucleotides 118&#x02013;139 (<xref ref-type="supplementary-material" rid="pgen.1000689.s006">Table S2</xref>) downstream of the ATG start codon. cDNA was amplified using primers PglpFK-extn-F and PglpFK-extn-R, and the PCR product was sequenced using the same primer (PglpFK-extn-R) as for cDNA synthesis. The transcriptional start site, i.e., the junction between the cDNA and the RNA oligonucleotide, was determined by sequencing.</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pgen.1000689.s001"><label>Figure S1</label><caption><p>Real-time PCR analysis of effects of the <italic>hns</italic> mutation on <italic>glpFK</italic> expression in <italic>wt</italic>, <italic>crp</italic> and <italic>crp</italic> Glp<sup>&#x0002b;</sup> backgrounds. Cells were grown in LB liquid medium.</p><p>(0.10 MB TIF)</p></caption><media xlink:href="pgen.1000689.s001.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000689.s002"><label>Figure S2</label><caption><p>Effects of IS5 and various regions within IS5 on expression of the downstream <italic>glpFK</italic> promoter in <italic>crp</italic> cells lacking IS5. &#x02018;IS&#x02019;, &#x02018;Pless&#x02019;, &#x02018;IB&#x02019;, &#x02018;none&#x02019;, and &#x02018;178&#x02019;, refer to transcriptional <italic>lacZ</italic> fusions for IS5:PglpFK, promoter-less IS5:P<italic>glpFK</italic>, IB:P<italic>glpFK</italic>, native P<italic>glpFK</italic>, and 178bp:P<italic>glpFK</italic>, respectively (see <xref ref-type="fig" rid="pgen-1000689-g001">Figure 1A</xref>). <italic>E. coli</italic> strain B has been reported to lack IS5 in its genome <xref ref-type="bibr" rid="pgen.1000689-Schneider1">&#x0005b;24&#x0005d;</xref>. The <italic>crp</italic> mutation was transferred to strain B by P1 transduction. The promoter:<italic>lacZ</italic> fusions described above were individually transferred to strain B <italic>crp</italic> cells from BW25113 by P1 transduction. For &#x003b2;-galactosidase assays, <italic>E. coli</italic> strain B <italic>crp</italic> cells containing these <italic>lacZ</italic> fusion constructs were grown in LB with shaking.</p><p>(0.12 MB TIF)</p></caption><media xlink:href="pgen.1000689.s002.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000689.s003"><label>Figure S3</label><caption><p>Effect of addition of an IHF binding site upstream of P<italic>glpFK</italic> on promoter activity. (A) The <italic>glpFK</italic> promoter region showing that an IHF binding site is added upstream of P<italic>glpFK</italic> by changing gccttgcagatta (&#x02212;222 to &#x02212;210) to aatcaagcagtta. The newly added IHF binding site is located at the same relative distance as in IB:P<italic>glpFK</italic>. (B) Effect of the added IHF site on P<italic>glpFK</italic> activity in <italic>wt</italic> and <italic>crp</italic> cells grown in LB medium. P<italic>glpFK</italic> and P<italic>glpFK</italic>_IHF refer to the transcriptional <italic>lacZ</italic> fusions for native P<italic>glpFK</italic> and the same promoter with an upstream IHF binding site, respectively.</p><p>(0.37 MB TIF)</p></caption><media xlink:href="pgen.1000689.s003.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000689.s004"><label>Figure S4</label><caption><p>Effect of A-tract mutations in IB on <italic>glpFK</italic> promoter activity in the <italic>ihfA</italic> genetic background. The IB:P<italic>glpFK-lacZ</italic> fusion with or without mutations in A-tracts 1&#x02013;3 in IB was transferred into the <italic>crp ihfA</italic> double genetic background. The cells were cultured in LB medium.</p><p>(0.12 MB TIF)</p></caption><media xlink:href="pgen.1000689.s004.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000689.s005"><label>Table S1</label><caption><p>Strains used in this study.</p><p>(0.06 MB DOC)</p></caption><media xlink:href="pgen.1000689.s005.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000689.s006"><label>Table S2</label><caption><p>Oligonucleotides used in this study.</p><p>(0.08 MB DOC)</p></caption><media xlink:href="pgen.1000689.s006.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank Drs. Barbara Wright and Karin Schnetz for critically reviewing this manuscript and Drs. Terry Hwa and David Meyer for helpful discussions.</p></ack><ref-list><title>References</title><ref id="pgen.1000689-Friedberg1"><label>1</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Friedberg</surname><given-names>EC</given-names></name><name><surname>Walker</surname><given-names>GC</given-names></name><name><surname>Siede</surname><given-names>W</given-names></name></person-group><year>1995</year><source>DNA Repair and Mutagenesis</source><publisher-loc>Washington, DC</publisher-loc><publisher-name>ASM Press</publisher-name></mixed-citation></ref><ref id="pgen.1000689-HenggeAronis1"><label>2</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hengge-Aronis</surname><given-names>R</given-names></name></person-group><year>2000</year><article-title>The general stress response in <italic>Escherichia coli</italic>.</article-title><person-group person-group-type="editor"><name><surname>Storz</surname><given-names>G</given-names></name><name><surname>Hengge-Aronis</surname><given-names>R</given-names></name></person-group><source>Bacterial Stress Response</source><publisher-loc>Washington, DC</publisher-loc><publisher-name>ASM Press</publisher-name><fpage>161</fpage><lpage>178</lpage></mixed-citation></ref><ref id="pgen.1000689-Chandler1"><label>3</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Chandler</surname><given-names>M</given-names></name><name><surname>Mahillon</surname><given-names>J</given-names></name></person-group><year>2002</year><article-title>Insertion sequences revised.</article-title><person-group person-group-type="editor"><name><surname>Craig</surname><given-names>NL</given-names></name><name><surname>Craigie</surname><given-names>R</given-names></name><name><surname>Gellert</surname><given-names>M</given-names></name><name><surname>Lambowitz</surname><given-names>AM</given-names></name></person-group><source>Mobile DNA II</source><publisher-loc>Washington, DC</publisher-loc><publisher-name>ASM Press</publisher-name><fpage>305</fpage><lpage>366</lpage></mixed-citation></ref><ref id="pgen.1000689-Mahillon1"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahillon</surname><given-names>J</given-names></name><name><surname>Chandler</surname><given-names>M</given-names></name></person-group><year>1998</year><article-title>Insertion sequences.</article-title><source>Microbiol Mol Biol Rev</source><volume>62</volume><fpage>725</fpage><lpage>774</lpage><pub-id pub-id-type="pmid">9729608</pub-id></mixed-citation></ref><ref id="pgen.1000689-Galas1"><label>5</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Galas</surname><given-names>DJ</given-names></name><name><surname>Chandler</surname><given-names>M</given-names></name></person-group><year>1989</year><article-title>Bacterial insertion sequences.</article-title><person-group person-group-type="editor"><name><surname>Berg</surname><given-names>D</given-names></name><name><surname>Howe</surname><given-names>M</given-names></name></person-group><source>Mobile DNA</source><publisher-loc>Washington DC</publisher-loc><publisher-name>American Society for Microbiology</publisher-name><fpage>109</fpage><lpage>162</lpage></mixed-citation></ref><ref id="pgen.1000689-Charlier1"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charlier</surname><given-names>D</given-names></name><name><surname>Piette</surname><given-names>J</given-names></name><name><surname>Glansdorff</surname><given-names>N</given-names></name></person-group><year>1982</year><article-title>IS3 can function as a mobile promoter in <italic>E. coli</italic>.</article-title><source>Nucleic Acids Res</source><volume>10</volume><fpage>5935</fpage><lpage>5948</lpage><pub-id pub-id-type="pmid">6292860</pub-id></mixed-citation></ref><ref id="pgen.1000689-Ciampi1"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciampi</surname><given-names>MS</given-names></name><name><surname>Schmid</surname><given-names>MB</given-names></name><name><surname>Roth</surname><given-names>JR</given-names></name></person-group><year>1982</year><article-title>Transposon Tn10 provides a promoter for transcription of adjacent sequences.</article-title><source>Proc Natl Acad Sci USA</source><volume>79</volume><fpage>5016</fpage><lpage>5020</lpage><pub-id pub-id-type="pmid">6289329</pub-id></mixed-citation></ref><ref id="pgen.1000689-Reynolds1"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>AE</given-names></name><name><surname>Felton</surname><given-names>J</given-names></name><name><surname>Wright</surname><given-names>A</given-names></name></person-group><year>1981</year><article-title>Insertion of DNA activates the cryptic <italic>bgl</italic> operon in <italic>E. coli</italic> K12.</article-title><source>Nature</source><volume>293</volume><fpage>625</fpage><lpage>629</lpage><pub-id pub-id-type="pmid">6270569</pub-id></mixed-citation></ref><ref id="pgen.1000689-Schnetz1"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schnetz</surname><given-names>K</given-names></name><name><surname>Rak</surname><given-names>B</given-names></name></person-group><year>1992</year><article-title>IS5: a mobile enhancer of transcription in <italic>Escherichia coli</italic>.</article-title><source>Proc Natl Acad Sci USA</source><volume>89</volume><fpage>1244</fpage><lpage>1248</lpage><pub-id pub-id-type="pmid">1311089</pub-id></mixed-citation></ref><ref id="pgen.1000689-Schnetz2"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schnetz</surname><given-names>K</given-names></name></person-group><year>1995</year><article-title>Silencing of <italic>Escherichia coli bgl</italic> promoter by flanking sequence elements.</article-title><source>EMBO J</source><volume>14</volume><fpage>2545</fpage><lpage>2550</lpage><pub-id pub-id-type="pmid">7781607</pub-id></mixed-citation></ref><ref id="pgen.1000689-Dole1"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dole</surname><given-names>S</given-names></name><name><surname>Nagarajavel</surname><given-names>V</given-names></name><name><surname>Schnetz</surname><given-names>K</given-names></name></person-group><year>2004</year><article-title>The histone-like nucleoid structuring protein H-NS represses the <italic>Escherichia coli bgl</italic> operon downstream of the promoter.</article-title><source>Mol Microbiol</source><volume>52</volume><fpage>589</fpage><lpage>600</lpage><pub-id pub-id-type="pmid">15066043</pub-id></mixed-citation></ref><ref id="pgen.1000689-Mukerji1"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukerji</surname><given-names>M</given-names></name><name><surname>Mahadevan</surname><given-names>S</given-names></name></person-group><year>1997</year><article-title>Characterization of the negative elements involved in silencing the <italic>bgl</italic> operon of <italic>Escherichia coli</italic>: possible roles for DNA gyrase, H-NS, and CRP-cAMP in regulation.</article-title><source>Mol Microbiol</source><volume>24</volume><fpage>617</fpage><lpage>627</lpage><pub-id pub-id-type="pmid">9179854</pub-id></mixed-citation></ref><ref id="pgen.1000689-Chen1"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YM</given-names></name><name><surname>Lu</surname><given-names>Z</given-names></name><name><surname>Lin</surname><given-names>ECC</given-names></name></person-group><year>1989</year><article-title>Constitutive activation of the <italic>fucAO</italic> operon and silencing of the divergently transcribed <italic>fucPIK</italic> operon by an IS5 element in <italic>Escherichia coli</italic> mutants selected for growth on L-1,2-propanediol.</article-title><source>J Bacteriol</source><volume>171</volume><fpage>6097</fpage><lpage>6105</lpage><pub-id pub-id-type="pmid">2553671</pub-id></mixed-citation></ref><ref id="pgen.1000689-Barker1"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barker</surname><given-names>CS</given-names></name><name><surname>Prub</surname><given-names>BM</given-names></name><name><surname>Matsumura</surname><given-names>P</given-names></name></person-group><year>2004</year><article-title>Increased motility of <italic>Escherichia coli</italic> by insertion sequence element integration into regulatory region of the <italic>flhD</italic> operon.</article-title><source>J Bacteriol</source><volume>186</volume><fpage>7529</fpage><lpage>7537</lpage><pub-id pub-id-type="pmid">15516564</pub-id></mixed-citation></ref><ref id="pgen.1000689-Petersen1"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>C</given-names></name><name><surname>Moller</surname><given-names>LB</given-names></name><name><surname>Valentin-Hansen</surname><given-names>P</given-names></name></person-group><year>2002</year><article-title>The cryptic adenine deaminase gene of <italic>Escherichia coli</italic>.</article-title><source>J Biol Chem</source><volume>277</volume><fpage>31373</fpage><lpage>31380</lpage><pub-id pub-id-type="pmid">12077137</pub-id></mixed-citation></ref><ref id="pgen.1000689-Lin1"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>ECC</given-names></name></person-group><year>1976</year><article-title>Glycerol dissimilation and its regulation in bacteria.</article-title><source>Annu Rev Microbiol</source><volume>30</volume><fpage>535</fpage><lpage>578</lpage><pub-id pub-id-type="pmid">825019</pub-id></mixed-citation></ref><ref id="pgen.1000689-Zhao1"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>N</given-names></name><name><surname>Oh</surname><given-names>W</given-names></name><name><surname>Trybul</surname><given-names>D</given-names></name><name><surname>Thrasher</surname><given-names>KS</given-names></name><name><surname>Kingsbury</surname><given-names>TJ</given-names></name><etal/></person-group><year>1994</year><article-title>Characterization of the interaction of the <italic>glp</italic> repressor of <italic>Escherichia coli</italic> with single and tandem <italic>glp</italic> operator variants.</article-title><source>J Bacteriol</source><volume>176</volume><fpage>2393</fpage><lpage>2397</lpage><pub-id pub-id-type="pmid">8157609</pub-id></mixed-citation></ref><ref id="pgen.1000689-Freedberg1"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freedberg</surname><given-names>WB</given-names></name><name><surname>Lin</surname><given-names>ECC</given-names></name></person-group><year>1973</year><article-title>Three kinds of controls affecting the expression of the <italic>glp</italic> regulon in <italic>Escherichia coli</italic>.</article-title><source>J Bacteriol</source><volume>115</volume><fpage>816</fpage><lpage>823</lpage><pub-id pub-id-type="pmid">4580569</pub-id></mixed-citation></ref><ref id="pgen.1000689-Weissenborn1"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weissenborn</surname><given-names>DL</given-names></name><name><surname>Wittekindt</surname><given-names>N</given-names></name><name><surname>Larson</surname><given-names>TJ</given-names></name></person-group><year>1992</year><article-title>Structure and regulation of the <italic>glpFK</italic> operon encoding glycerol diffusion facilitator and glycerol kinase of <italic>Escherichia coli</italic> K-12.</article-title><source>J Biol Chem</source><volume>267</volume><fpage>6122</fpage><lpage>6131</lpage><pub-id pub-id-type="pmid">1372899</pub-id></mixed-citation></ref><ref id="pgen.1000689-Zeng1"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>G</given-names></name><name><surname>Ye</surname><given-names>S</given-names></name><name><surname>Larson</surname><given-names>TJ</given-names></name></person-group><year>1996</year><article-title>Repressor for the sn-glycerol 3-phosphate regulon of <italic>Escherichia coli</italic> K-12: primary structure and identification of the DNA-binding domain.</article-title><source>J Bacteriol</source><volume>178</volume><fpage>7080</fpage><lpage>7089</lpage><pub-id pub-id-type="pmid">8955387</pub-id></mixed-citation></ref><ref id="pgen.1000689-Zhang1"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Saier</surname><given-names>MH</given-names><suffix>Jr</suffix></name></person-group><year>2009</year><article-title>A mechanism of transposon-mediated directed mutation.</article-title><source>Mol Microbiol</source><comment>in press</comment></mixed-citation></ref><ref id="pgen.1000689-Kroger1"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroger</surname><given-names>M</given-names></name><name><surname>Hobom</surname><given-names>G</given-names></name></person-group><year>1982</year><article-title>Structural analysis of insertion sequence IS5.</article-title><source>Nature</source><volume>297</volume><fpage>159</fpage><lpage>162</lpage><pub-id pub-id-type="pmid">6281654</pub-id></mixed-citation></ref><ref id="pgen.1000689-Rak1"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rak</surname><given-names>B</given-names></name><name><surname>Lusky</surname><given-names>M</given-names></name><name><surname>Hable</surname><given-names>M</given-names></name></person-group><year>1982</year><article-title>Expression of two proteins from overlapping and oppositely oriented genes on transposable DNA insertion element IS5.</article-title><source>Nature</source><volume>297</volume><fpage>124</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">6281651</pub-id></mixed-citation></ref><ref id="pgen.1000689-Schneider1"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>D</given-names></name><name><surname>Duperchy</surname><given-names>E</given-names></name><name><surname>Depe yrot</surname><given-names>J</given-names></name><name><surname>Coursange</surname><given-names>E</given-names></name><name><surname>Lenski</surname><given-names>RG</given-names></name><etal/></person-group><year>2002</year><article-title>Genomic comparisons among <italic>Escherichia coli</italic> strains B, K-12 and O157:Hy using elements as molecular markers.</article-title><source>BMC Microbiol</source><volume>2</volume><fpage>8 pgs</fpage><pub-id pub-id-type="pmid">12022921</pub-id></mixed-citation></ref><ref id="pgen.1000689-Muramatsu1"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muramatsu</surname><given-names>S</given-names></name><name><surname>Kato</surname><given-names>M</given-names></name><name><surname>Kohara</surname><given-names>Y</given-names></name><name><surname>Mizuno</surname><given-names>T</given-names></name></person-group><year>1988</year><article-title>Insertion sequence IS5 contains a sharply curved DNA structure at its terminus.</article-title><source>Mol Gen Genet</source><volume>214</volume><fpage>433</fpage><lpage>438</lpage><pub-id pub-id-type="pmid">2851094</pub-id></mixed-citation></ref><ref id="pgen.1000689-DiNardo1"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiNardo</surname><given-names>S</given-names></name><name><surname>Voelkel</surname><given-names>KA</given-names></name><name><surname>Sternglanz</surname><given-names>R</given-names></name><name><surname>Reynolds</surname><given-names>AE</given-names></name><name><surname>Wright</surname><given-names>A</given-names></name></person-group><year>1982</year><article-title><italic>Escherichia coli</italic> DNA topoisomerase I mutants have compensatory mutations in DNA gyrase genes.</article-title><source>Cell</source><volume>31</volume><fpage>43</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">6297752</pub-id></mixed-citation></ref><ref id="pgen.1000689-Higgins1"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgins</surname><given-names>CF</given-names></name><name><surname>Dorman</surname><given-names>CJ</given-names></name><name><surname>Stirling</surname><given-names>DA</given-names></name><name><surname>Waddell</surname><given-names>L</given-names></name><name><surname>Booth</surname><given-names>IR</given-names></name><etal/></person-group><year>1988</year><article-title>A physiological role for DNA supercoiling in the osmotic regulation of gene expression in <italic>S. typhimurium</italic> and <italic>E. coli</italic>.</article-title><source>Cell</source><volume>52</volume><fpage>569</fpage><lpage>584</lpage><pub-id pub-id-type="pmid">2830029</pub-id></mixed-citation></ref><ref id="pgen.1000689-Giel1"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giel</surname><given-names>M</given-names></name><name><surname>Desnoyer</surname><given-names>M</given-names></name><name><surname>Lopilato</surname><given-names>J</given-names></name></person-group><year>1996</year><article-title>A mutation in a new gene, <italic>bglJ</italic>, activates the <italic>bgl</italic> operon in <italic>Escherichia coli</italic> K-12.</article-title><source>Genetics</source><volume>143</volume><fpage>627</fpage><lpage>635</lpage><pub-id pub-id-type="pmid">8725214</pub-id></mixed-citation></ref><ref id="pgen.1000689-Stratmann1"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stratmann</surname><given-names>T</given-names></name><name><surname>Madhusudan</surname><given-names>S</given-names></name><name><surname>Schnetz</surname><given-names>K</given-names></name></person-group><year>2008</year><article-title>Regulation of the <italic>yjjQ-bglJ</italic> operon, encoding LuxR-type transcription factors, and the divergent <italic>yjjP</italic> gene by H-NS and LeuO.</article-title><source>J Bacteriol</source><volume>190</volume><fpage>926</fpage><lpage>935</lpage><pub-id pub-id-type="pmid">18055596</pub-id></mixed-citation></ref><ref id="pgen.1000689-Lopilato1"><label>30</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lopilato</surname><given-names>J</given-names></name><name><surname>Wright</surname><given-names>A</given-names></name></person-group><year>1990</year><article-title>Mechanisms of activation of the cryptic <italic>bgl</italic> operon of <italic>Escherichia coli</italic> K-12.</article-title><person-group person-group-type="editor"><name><surname>Drlica</surname><given-names>K</given-names></name><name><surname>Riley</surname><given-names>M</given-names></name></person-group><source>The bacterial chromosome</source><publisher-loc>Washington, D.C.</publisher-loc><publisher-name>American Society for Microbiology</publisher-name><fpage>435</fpage><lpage>444</lpage></mixed-citation></ref><ref id="pgen.1000689-Ueguchi1"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueguchi</surname><given-names>C</given-names></name><name><surname>Ohta</surname><given-names>T</given-names></name><name><surname>Seto</surname><given-names>C</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Mizuno</surname><given-names>T</given-names></name></person-group><year>1998</year><article-title>The <italic>leuO</italic> gene product has a latent ability to relieve <italic>bgl</italic> silencing in <italic>Escherichia coli</italic>.</article-title><source>J Bacteriol</source><volume>180</volume><fpage>190</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">9422614</pub-id></mixed-citation></ref><ref id="pgen.1000689-Reynolds2"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>A</given-names></name><name><surname>Mahadevan</surname><given-names>ES</given-names></name><name><surname>LeGrice</surname><given-names>SF</given-names></name><name><surname>Wright</surname><given-names>A</given-names></name></person-group><year>1986</year><article-title>Enhancement of bacterial gene expression by insertion elements or by mutation in a CAP-cAMP binding site.</article-title><source>J Mol Biol</source><volume>191</volume><fpage>85</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">3025456</pub-id></mixed-citation></ref><ref id="pgen.1000689-Prentki1"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prentki</surname><given-names>P</given-names></name><name><surname>Chandler</surname><given-names>M</given-names></name><name><surname>Galas</surname><given-names>DJ</given-names></name></person-group><year>1987</year><article-title><italic>Escherichia coli</italic> integration host factor bends the DNA at the ends of IS1 and in an insertion hotspot with multiple IHF binding sites.</article-title><source>EMBO J</source><volume>6</volume><fpage>2479</fpage><lpage>2487</lpage><pub-id pub-id-type="pmid">2822395</pub-id></mixed-citation></ref><ref id="pgen.1000689-Koo1"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koo</surname><given-names>HS</given-names></name><name><surname>Wu</surname><given-names>HM</given-names></name><name><surname>Crothers</surname><given-names>DM</given-names></name></person-group><year>1986</year><article-title>DNA bending at adenine &#x02022; thymine tracts.</article-title><source>Nature</source><volume>320</volume><fpage>501</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">3960133</pub-id></mixed-citation></ref><ref id="pgen.1000689-Aiyar1"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aiyar</surname><given-names>SE</given-names></name><name><surname>Gourse</surname><given-names>RL</given-names></name><name><surname>Ross</surname><given-names>W</given-names></name></person-group><year>1998</year><article-title>Upstream A-tracts increase bacterial promoter activity through interactions with the RNA polymerase &#x003b1;-subunit.</article-title><source>Proc Natl Acad Sci USA</source><volume>95</volume><fpage>14652</fpage><lpage>14657</lpage><pub-id pub-id-type="pmid">9843944</pub-id></mixed-citation></ref><ref id="pgen.1000689-Bracco1"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bracco</surname><given-names>L</given-names></name><name><surname>Kotlarz</surname><given-names>D</given-names></name><name><surname>Kolb</surname><given-names>A</given-names></name><name><surname>Diekmann</surname><given-names>S</given-names></name><name><surname>Buc</surname><given-names>H</given-names></name></person-group><year>1989</year><article-title>Synthetic curved DNA sequences can act as transcriptional activators in <italic>Escherichia coli</italic>.</article-title><source>EMBO J</source><volume>8</volume><fpage>4289</fpage><lpage>4296</lpage><pub-id pub-id-type="pmid">2512122</pub-id></mixed-citation></ref><ref id="pgen.1000689-Giladi1"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giladi</surname><given-names>H</given-names></name><name><surname>Koby</surname><given-names>S</given-names></name><name><surname>Prag</surname><given-names>G</given-names></name><name><surname>Engelhorn</surname><given-names>M</given-names></name><name><surname>Geiselmann</surname><given-names>J</given-names></name><etal/></person-group><year>1998</year><article-title>Participation of IHF and a distant UP element in the stimulation of the phage &#x003bb; P<sub>L</sub> promoter.</article-title><source>Mol Microbiol</source><volume>30</volume><fpage>443</fpage><lpage>451</lpage><pub-id pub-id-type="pmid">9791187</pub-id></mixed-citation></ref><ref id="pgen.1000689-Gosset1"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gosset</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Nayyar</surname><given-names>S</given-names></name><name><surname>Cuevas</surname><given-names>WA</given-names></name><name><surname>Saier</surname><given-names>MH</given-names><suffix>Jr</suffix></name></person-group><year>2004</year><article-title>Transcriptome analysis of Crp-dependent catabolite control of gene expression in <italic>Escherichia coli</italic>.</article-title><source>J Bacteriol</source><volume>186</volume><fpage>3516</fpage><lpage>2524</lpage><pub-id pub-id-type="pmid">15150239</pub-id></mixed-citation></ref><ref id="pgen.1000689-Kuhlman1"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuhlman</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Saier</surname><given-names>MH</given-names><suffix>Jr</suffix></name><name><surname>Hwa</surname><given-names>T</given-names></name></person-group><year>2007</year><article-title>Combinatorial transcriptional control of the lactose operon of <italic>Escherichia coli</italic>.</article-title><source>Proc Natl Acad Sci USA</source><volume>104</volume><fpage>6043</fpage><lpage>6048</lpage><pub-id pub-id-type="pmid">17376875</pub-id></mixed-citation></ref><ref id="pgen.1000689-Datsenko1"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Datsenko</surname><given-names>KA</given-names></name><name><surname>Wanner</surname><given-names>BL</given-names></name></person-group><year>2000</year><article-title>One-step inactivation of chromosomal genes in <italic>Escherichia coli</italic> k-12 using PCR products.</article-title><source>Proc Natl Acad Sci USA</source><volume>97</volume><fpage>6640</fpage><lpage>6645</lpage><pub-id pub-id-type="pmid">10829079</pub-id></mixed-citation></ref><ref id="pgen.1000689-Aboulwafa1"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aboulwafa</surname><given-names>M</given-names></name><name><surname>Saier</surname><given-names>MH</given-names><suffix>Jr</suffix></name></person-group><year>2004</year><article-title>Characterization of soluble enzyme II complexes of the <italic>Escherichia coli</italic> phosphotransferase system.</article-title><source>J Bacteriol</source><volume>186</volume><fpage>8453</fpage><lpage>8462</lpage><pub-id pub-id-type="pmid">15576795</pub-id></mixed-citation></ref><ref id="pgen.1000689-Zhang2"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Gosset</surname><given-names>G</given-names></name><name><surname>Barabote</surname><given-names>R</given-names></name><name><surname>Gonzalez</surname><given-names>GS</given-names></name><name><surname>Cuevas</surname><given-names>WA</given-names></name><etal/></person-group><year>2005</year><article-title>Functional interactions between the carbon and iron utilization regulators, Crp and Fur, in <italic>Escherichia coli</italic>.</article-title><source>J Bacteriol</source><volume>187</volume><fpage>980</fpage><lpage>990</lpage><pub-id pub-id-type="pmid">15659676</pub-id></mixed-citation></ref><ref id="pgen.1000689-McHugh1"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McHugh</surname><given-names>JP</given-names></name><name><surname>Rodriguez-Quinones</surname><given-names>F</given-names></name><name><surname>Abdul-Tehrani</surname><given-names>H</given-names></name><name><surname>Svistunenko</surname><given-names>DA</given-names></name><name><surname>Poole</surname><given-names>RK</given-names></name><etal/></person-group><year>2003</year><article-title>Global iron dependent gene regulation in <italic>Escherichia coli</italic>. A new mechanism for iron homeostasis.</article-title><source>J Biol Chem</source><volume>278</volume><fpage>29478</fpage><lpage>29486</lpage><pub-id pub-id-type="pmid">12746439</pub-id></mixed-citation></ref><ref id="pgen.1000689-Simons1"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simons</surname><given-names>RW</given-names></name><name><surname>Houman</surname><given-names>F</given-names></name><name><surname>Kleckner</surname><given-names>N</given-names></name></person-group><year>1987</year><article-title>Improved single and multicopy <italic>lac</italic>-based cloning vectors for protein and operon fusions.</article-title><source>Gene</source><volume>53</volume><fpage>85</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">3596251</pub-id></mixed-citation></ref><ref id="pgen.1000689-Miller1"><label>45</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>JH</given-names></name></person-group><year>1972</year><source>Experiments in Molecular Genetics</source><publisher-loc>Cold Spring Harbor, NY</publisher-loc><publisher-name>Cold Spring Harbor Laboratory</publisher-name></mixed-citation></ref><ref id="pgen.1000689-Bensing1"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bensing</surname><given-names>BA</given-names></name><name><surname>Meyer</surname><given-names>BJ</given-names></name><name><surname>Dunny</surname><given-names>GM</given-names></name></person-group><year>1996</year><article-title>Sensitive detection of bacterial transcription initiation sites and differentiation from RNA processing sites in the pheromone-induced plasmid transfer system of <italic>Enterococcus faecalis</italic>.</article-title><source>Proc Natl Acad Sci USA</source><volume>93</volume><fpage>7794</fpage><lpage>7799</lpage><pub-id pub-id-type="pmid">8755555</pub-id></mixed-citation></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p>This work was supported by NIH grants GM 64368 and GM 077402. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article>